The immediate effect of sudden blood loss is the activation 'of a variety of homeostatic responses. These include increased sympathetic activity and increased release or production of renin, angiotensin, anti-diuretic hormone, aldosterone, adrenocorticotrophic hormone, betaendorphins, glucocorticoids, glucagon, erythropoeitin, 2-3 diphosphoglycerate, prostaglandins and complement. This may be followed by the release of many substances, some initially appropriate locally, and some the products of damaged celts, which may go on to cause both local and systemic damage. These include lysozomal enzymes, kin ins, histamines, serotonin, lactic acid, free oxygen radicals, neutrophil pro teases, fibrinogen degradation products, endotoxins, myocardial depressant polypeptides, and passive transferable lethal factor. The early and late effects on the cardiovascular and respiratory systems, and on the blood, brain, kidneys, gut, liver, pancreas, and on overaff metabolism and cellular function, are considered in turn. Although an enormous research effort has increased our understanding of the pathophysiology of haemorrhagic shock, no special measures have yet been shown to influence morbidity or mortality in man. Management still hinges on the early recognition and treatment of bleeding, on general supportive measures, and on safeguarding each link in the oxygen delivery chain.
maintenance of an adequate blood volume and central venous pressure with an intravenous infusion of warm saline led to reduced mortality in experimental haemorrhagic shock, but, in spite of this, saline infusions gained slow acceptance over the next 20 years, and blood transfusion remained rare right through the 1920s. Crile subscribed to the "vasomotor exhaustion" theory of shock, which had been popular throughout the nineteenth century, and which was to remain so until the end of the First World War. 3 The modern understanding of shock dates from field studies carried out behind the lines in the First World War by workers such as Cannon, Bayliss and McLean. 3 As a result of these studies, it became generally accepted that shock was caused by tissue hypoxia due to inadequate oxygen delivery as a result of failure of tissue perfusion, with the resultant lactic acidosis from anaerobic metabolism producing the characteristic compensatory hyperventilation. Cannon pointed out that acute circulatory failure, or shock, could be caused by "pump failure", by hypovolaemia, or by inappropriately increased capacity of the circulatory bed. In haemorrhagic shock, of course, both hypovolaemia and reduced blood oxygen carrying capacity contribute to the reduction in tissue oxygen delivery. It is now recognised that this inadequate tissue perfusion is accompanied, very early on, by abnormal cellular metabolism which contributes to the complex physiological and biochemical features of shock. 4 The pathophysiology of shock has been the subject of a huge research effort, as manifested by the enormous bibliographies in reviews of the subject (over 2000 references were cited in a recent publication 5 ) . However, studies in man have been hampered by iogisrical and erhical constraints, and interpretation of animal work has been plagued by different models and species often yielding quite different results. For this reason, only key papers and comprehensive reviews will be cited in this brief review.
TABLE I
Homeostatic responses in haemorrhagic shock I. SYMPATHETIC ACTIVITY This is mediated by baro-and chemo-receptors, pain, and anxiety and results in an increase in rate and force of myocardial contraction and widespread arteriolar and veno-constriction diverting available blood flow to heart and brain. 6 See Cardiovascular System for details.
CIRCULATING CATECHOLAMINES
There may be ten to fortyfold increases in the concentrations of circulating adrenaline and noradrenaline (up to 3 and 7 ng/ml respectively) in haemorrhagic shock. The noradrenaline represents spill-over from synaptic clefts, whereas the adrenaline is released from the adrenal medulla. The circulating catecholamines augment the effects of the increased sympathetic nervous system activity. However, the specific effects of any catecholamine on any particular end-organ may be modulated locally by at least 20 different mechanisms, and may vary from species to species, from individual to individual, and from organ to organ.?
RENIN-ANGIOTENSIN
In haemorrhagic shock there is an increase in renin secretion by the renal juxtaglomerular apparatus due to reduced glomerular blood flow, to decreased sodium delivery to the macula densa of the distal tubule, to reduced renal afferent arteriolar pressure, and to increased sympathetic activity. The resultant increased circulating angiotensin causes vasoconstriction and plays a role in maintaining the blood pressure in haemorrhagic shock, and also causes aldosterone release. 8 (See The Kidney.) 4 . ANTI-DIURETIC HORMONE (ADH) ADH secretion by the posterior pituitary is normally mediated via osmoreceptors in the hypothalamus in' response to increased body fluid osmolality. In shock, this may be augmented by decreased discharge of arterial and atrial baroreceptors. ADH has been shown to play a role in the maintenance of blood pressure in haemorrhagic shock by contributing to the splanchnic vasoconstriction, and by permitting distal renal tubular and collecting duct reabsorption of water. 9 
ALDOSTERONE
There is increased release of aldosterone due to the increased release of renin, which leads to an increase in the renal distal tubular reabsorption of sodium (and water) and in the excretion of potassium, which is released from damaged cells. 9 6. ADRENOCORTICOTROPHIC HORMONE AND BETA-ENDORPHIN The endogenous opiate beta-endorphin is stored and concomitantly regulated with pituitary ACTH, and both are released after sudden blood loss, presumably by activation of hypothalamic releasing factors. The ACTH causes increased release of glucocorticoids, whereas the endorphins may have effects on reducing pain perception and may play a role in perpetuating hypotension, as naloxone administration may reduce the fall in blood pressure. ID 
GLUCOCORTICOIDS
Circulating glucocorticoid concentrations increase in haemorrhagic shock, and at least these high physiological blood concentrations of cortisol may be necessary for a normal homeostatic response in shock. Hence, physiological doses of glucocorticoids should be administered to patients on long-term steroid therapy or with Addison's disease. There has been experimental work in animals which suggests that pharmacological doses of steroids increase survival in haemorrhagic shock. There has been no controlled study in man.!! 8. GLUCAGON Glucagon is secreted by the alpha cells of the pancreatic islets. Its main site of action is the liver, where it stimulates gluconeogenesis. Free fatty acid and glycerol production from adipose tissue is also stimulated. Stress, catecholamines, and hypoglycaemia all stimulate glucagon secretion.!2 9. ERYTHROPOEITIN After significant blood loss there is an increase in circulating erythropoeitin, with an increase in reticulocytes in peripheral blood. Normal red blood cell volume is restored within 4-8 weeks. Most erythropoeitin is produced by the kidneys, probably from cells in the glomeruli, although small amounts may come from other organs. Its secretion is stimulated by anaemia, hypoxia, and bv catecholamines via beta receptors. It acts on a group of erythropoeitin-sensitive stem cells in the bonemarrow, resulting in increased red blood cell production. 9 
2-3 DIPHOSPHOGL YCERATE
After acute blood loss there is an increase in 2-3 diphosphoglycerate (2-3 DPG) in the red blood cells. 2-3 DPG is a product of glycolysis via the Embden-Meyerhoff pathway, and is very plentiful in red blood cells. It is a highly charged anion, which binds to deoxygenated haemoglobin, but not to oxyhaemoglobin; thus an increase in 2-3 DPG concentration increases liberation of oxygen. Acidosis inhibits red cell glycolysis leading to decreased 2-3 DPG concentrations. On the other hand, hypoxia, exercise and shock cause 2-3 DPG concentrations to increase.
PROSTAGLANDINS
The prostaglandins comprise several carboxylic acid compounds synthesised from essential fattv acids in cellular microsomes; there is much debate ~s to their role in haemorrhagic shock. PGE2 and PGI2 are vasodilators and may be locally produced by organs such as liver and kidney, and may have some protective influence early in shock. PGI2 is also a potent inhibitor of platelet aggregation; however, production by endothelial cells may fail in shock states. I) Prostaglandins PGF2-alpha and PGA2 are both vasoconstrictors. PGF2-alpha concentrations rise in haemorrhagic shock and may contribute to both the pulmonary and systemic vasoconstriction. 14 PGA2 also causes platelet aggregation and may play a role in the production of DIe. Neither blockade of prostaglandin synthesis nor infusion of PGE2 have increased survival in experimental haemorrhagic shock.12 12. COMPLEMENT ACTIVATION
The complement system consists of a cascading series of plasma enzymes similar to the coagulation pathway. Complement is involved in the cell lysis, opsonization, leucocyte chemotaxis and histamine release which normally follows antigen-antibody binding. 9 Complement activation can also occur in the absence of antibodies, via the alternative or properdin pathway. In shock, excessive complement activation via this pathway results in disordered leucocyte function which is especially important in the production of ARDS.14 The immediate effect of sudden blood loss is the activation of a variety of homeostatic mechanisms (Table 1 ). This is accompanied or very soon followed by the local release of a wide variety of substances, many of which constitute appropriate responses to local injury, but which may cause deleterious effects when released in large quantities into the blood Table 2 ). If the blood loss is substantial and remains untreated, this is followed by the release of the contents of hypoxic or dying cells, many of which cause both local and systemic damage ( Table 2 ). These early and late effects of haemorrhagic shock will be discussed, system by system, followed by a brief note on practical implications. 
. HISTAMINE
Histamine may normally play a role as a cotransmitter in the regulation of the microcirculation under hypoxic or ischaemic conditions. 9 . 16 Histamine release from damaged cells causes increased capillary permeability; the histamine release in shock states is not endogenous mast cell histamine, and is not blocked by antihistamines 4 (see Complement Activation).
SEROTONIN
Serotonin (S-hydroxytryptamine) is found in high concentrations in platelets, in the chromafin cells of the gut, and in areas of the brain, where it may play a role in sleep and the regulation of circadian rhythms. Serotonin released from platelets exerts a strong local vasoconstrictor effect on arteries and arterioles. 9 
FIBRONECTlN
Fibronectin, an important adhesive glycoprotein organiser of tissue topography in the interstitium, is also an essential serum opsonin for the effective phagocytic function of the reticuloendothelial system. Fibronectin is depleted in patients with haemorrhagic shock, trauma, sepsis, and DIC, thus allowing particulate matter such as cellular debris and FOPs to circulate for prolonged periods in these states. 14 6 . LACTIC ACID Inadequate tissue perfusion leads to increased anaerobic glycolysis and the production of large amounts of lactic acid, leading to a tenfold increase (to 10 mmolll) in the concentration of circulating lactic acid. This may further reduce cardiac output by myocardial depression, and may also reduce receptor sensitivity to catecholamines 12 (see Cardiac Output and Metabolic and Cellular Changes). 7. FREE OXYGEN RADICALS Complement activation has been shown experimentally to reproduce ARDS by a mechanism involving leucocyte aggregation in the pulmonary microvasculature. The probable mediator of this leucocyte aggregation is the peptide C5a or one of its metabolites.I 4 Superoxide and other free oxygen radicals released by the aggregated leucocytes have been implicated in causing the damage to pulmonary capillary endothelial cells which leads to the capillary leakage typical of ARDS.17 8 
. NEUTROPHIL PROTEASES
The neutrophils which have aggregated in the pulmonary microvasculature (see 7 above) also release neutral and acid pro teases which destroy both structural proteins (collagen, elastin and fibronectin) and circulating proteins (plasma proteins, fibrinogen, Hageman factor, and complement).18 Thus lung architecture is destroyed, DIC is precipitated, and complement is activated, leading to further leucocyte aggregation. Normal protease inhibitors, such as alpha1-antitrypsin, may be inhibited by both oxygen and the superoxide radical. 14 
FIBRINOGEN DEGRADATION PRODUCTS
Fibrinolysis is normally a continuous process in the vascular tree which, in fact, is lined by a layer of fibrin.19 Fibrinolysin (plasmin) lyses fibrin and fibrinogen, with the production of a number of fibrinogen degradation products, which inhibit thrombin. Fibrinolysin is formed when profibrinolysin is acted upon by a plasma activator, which itself is converted from a proactivator by proteolytic fragments of factor XII called prekallikrein activators, which are also involved in kinin formation 9 (see 2 above). FDPs may have significant anti-coagulant effects when production is increased (e.g. with DIC), or when excretion is impaired (e.g. with renal failure) (see Blood, and Disseminated Intravascular Coagulation).
ENDOTOXIN
Intestinal bacteria and endotoxin may gain access to the circulation in severe haemorrhagic shock due to ischaemic damage to the gut mucosa (see The Gastrointestinal Tract) and because of failure of phagocytosis by the hepatic sinusoidal reticuloendothelial cells (see The Liver). Both grampositive and gram-negative bacteria produce toxins; however, the classical endotoxin is lipid A, a concealed membrane fragment of low antigenicity. Endotoxin may interfere with cellular oxygen utilisation both by an effect on microvasculature control and by a direct effect on cellular respiration. Endotoxin damages both cellular and mitochondrial membranes, and may activate both the coagulation and the complement pathways. 13 11. MYOCARDIAL DEPRESSANT POLYPEPTIDES At least nine myocardial depressant polypeptides, with molecular weights between 250 and 1000, are released in shock states by lysozomal enzyme fragmentation of cellular proteins (see 1 above). The depressant effect has been demonstrated in both intact anirhals and in isolated papillary muscle preparations, and is independent of electrolyte and hydrogen ion status and of changes in coronary blood flow or preload.I 3 The archetypal substance is myocardial depressant factor (MDF) (see The Pancreas).
PASSIVE TRANSFERABLE LETHAL FACTOR
Passive transferable lethal factor is a high molecular weight (16,000) substance which is found in the circulation in shock states and after cardiopulmonary bypass. It acts by producing myocardial depression, and is released by the reticulo-activating system. 13
THE CARDIOVASCULAR SYSTEM
Increased sympathetic discharge occurs shortly after the sudden loss of blood. This is precipitated by reduced stimulation of carotid, aortic, and major arterial baroreceptors, leading to less inhibition of the vasomotor centre in the medulla. Right atrial pressure receptors may also play a role, and the sympathetic activity may be augmented by pain, anxiety, and chemoreceptor stimulation. 6 Initially, even though there may be no reduction in mean arterial pressure, the reduced pulse pressure results in a reduced rate of discharge by the arterial baroreceptors. This rate is further reduced as mean arterial pressure falls. However, there is no baroreceptor discharge at systolic pressures below about 70 mmHg, and the vasomotor centre is then driven by chemoreceptors in the carotid and aortic bodies at a rate greater than that produced by this total removal of baroreceptor inhibition. 6 Low blood flow, anaemia and acidosis have all been shown to contribute to chemoreceptor stimulation. 20 This increase in sympathetic activity results in an increase in heart rate and con tractility and in generalised arteriolar and venous constriction. Local autoregulatory blood flow mechanisms are initially overridden by this sympathetic discharge, and the reduced available blood flow is diverted away from the splanchnic bed and peripheral circulation to the myocardium and brain. 21 "Reservoirs" of blood in the liver, spleen, splanchnic bed, subcutaneous tissues, large veins and pulmonary circulation are also mobilised by the sympathetic nervous system-mediated reduction in vascular capacity in these regions. 21 These effects may be augmented by a ten to twentyfold increase in circulating catecholamines (Table 1) , which may also stimulate the reticulo-activating system and contribute to the hyperventilation, restlessness and apprehension of the hypovolaemic patient. 7 A1ean arterial pressure may be well maintained after the sudden loss of up to 25070 of blood volume in healthy individuals. 22 While the sympathetic nervous system-mediated peripheral vasoconstriction, tachycardia and increased myocardial contractility are important in this respect, angiotensin II and vasopressin have also been shown to play significant roles in maintaining the blood pressure, as the administration of antagonists to either of these substances during experimentally induced haemorrhagic shock results in more profound hypotension. 12 The clinical significance of the effects on the blood pressure of some of the other substances released in haemorrhagic shock has not been established. Endorphins may contribute to the hypotension, and, experimentally, this may be antagonised with large doses of naloxone. 10 Concentrations of the vasodilator prostaglandin PGE2 are also elevated in haemorrhagic shock, but blockade of prostaglandin synthesis has not increased survival in haemorrhagic shock.12 Lactic acidosis may reduce peripheral vascular sensitivity to catecholamines, and circulating kinins, polypeptide fragments and histamine may all contribute to the hypotension (Tables I  and 2 ). 13 Cardiac output may initially be maintained by increases in venous return, heart rate, and myocardial contractility, mediated by the sympathetic nervous system, but falls progressively if blood volume continues to be reduced by more than 15070. 4 Venous return falls if the hypovolaemia remains uncorrected, and as the shock state progresses, myocardial contractility itself may be reduced by lactic acidosis, by myocardial depressant polypeptides released from disrupted cells, by lysozomal enzymes, and by "passive transferable lethal factor" produced by the reticulo-endothelial system ( ventricular end-diastolic pressure rises, and this, combined with the falling arterial diastolic pressure and rising heart rate, may compromise myocardial oxygenation, particularly in the subendocardial region. 24 Blood volume. In the early stages of haemorrhagic hypovolaemia, as a result of arteriolar constriction and low venous pressures, capillary pressures are low, and fluid moves into the capillaries, depleting interstitial, and then intracellular fluid. 25 There is also influx of preformed albumin from extravascular stores (up to 4 grams/hour).9 However, the rate of influx of fluid into the vascular system is relatively slow (about 100 mllhour) and plasma volume may not be fully restored for two days.12 There is reduced renal loss of fluid due to a reduced glomerular filtration rate as well as to the effects of increased renin, aldosterone and ADH concentrations (Table 1) . Other plasma protein losses are replaced over several days by hepatic synthesis. Erythropoeitin concentrations increase in the circulation, and the red cell mass is usually restored in 5-10 weeks (see Table 1 ). 9 The microcirculation normally controls autoregulation of tissue blood flow and the balance between intra-and extra-vascular hydrostatic and osmotic forces, and by its characteris tic vasomotion, intermi tten tly diverts blood through different portions of the capillary bed. 1l With the loss of 20-25070 of the blood volume, there is intense ischaemia of the microvascular bed due to precapillary vasoconstriction. Initially, the lowered intracapillary pressure favours a net gain of intravascular fluid from interstitial and intracellular fluid. However, if this state persists, there is loss of autoregulation and of spontaneous vasomotion accompanied by an increase in permeability of the vessel walls. 12 Ultimately, precapillary vasoconstriction fails due to hypoxia and to the local release of substances such as kinins, lysozomal enzymes, peptide fragments, serotinin, histamine and prostaglandins 26 (see Tables 1 and 2 ). The result is a loss of intravascular contents into the interstitial space, causing further hypovolaemia and reduced venous return. 27 BLOOD Oxygen supply is reduced by the loss of red cell mass. Acidosis and an increase in red cell 2-3-diphosphoglycerate improve unloading of oxygen at tissue level (Table 1) . However, this may be offset by poor microcirculatory blood flow. As a further result of the very sluggish flow in the microcirculation, red cells form rouleaux and platelets aggregate, rendering the blood highly susceptible to coagulation. 13 This low flow state sets the stage for disseminated intravascular coagulation (DIC), which may then be precipitated by many factors. Disruption of the integrity of the endothelium exposing highly thrombogenic collagen fibres, failure of synthesis of the platelet-inhibiting prostacyclin (PG 12), hypoxia, acidosis, endotoxins, histamine, catecholamines, steroids, and cellular peptide fragments may all contribute ( Table 2) . 19 The DIC further impedes flow and may consume all available coagulation factors and platelets, so that widespread bleeding may result.
DIC has adverse effects on every known element of coagulation. 19 It inhibits platelet aggregation, depletes clotting factors I-XIII, and converts profibrinolysin to fibrinolysin ( Table 2 ). DIC also produces circulating substances with anti-coagulant properties, including fibrin and fibrinogen breakdown products and a heparin-like substance. These substances may protect individuals from fulminating rapid DIC in the early stages, but may hasten the patient's demise once uncontrollable bleeding has begun. The importance of DIC as a cause of organ failure due to microinfarction of vital organs has been underestimated because post mortem fibrinolysis removes the evidence of clotting in small vessels within half an hour of death. 19
THE BRAIN
Available blood flow is preferentially directed to the brain and heart early in haemorrhagic shock, and it is rare for the brain to suffer global or focal ischaemia even with profound hypotension in elderly patients. 21 When brain damage does occur it appears that the injury is mainly along the lines of the arterial border zones. 28 The brain plays a central role in coordinating early compensatory responses after sudden blood 10SS. 13 Afferent stimuli include pain, anxiety, hypotension, changes in oxygen and carbon dioxide tension, and changes in hydrogen ion concentration. Integration of these signals probably takes place mainly in the medulla and hypothalamus, with neural outflow taking place via the autonomic nervous system and endocrine outflow via the hypothalamico-pituitary axis. Increased ADH, aldosterone and cortisol release help to conserve sodium and water, and increased catecholamine, glucagon, cortisol and growth hormone release promotes hyperglycaemia, ensuring an adequate supply of substrate for anaerobic metabolism. 13 
THE RESPIRATORY SYSTEM
The early respiratory response to sudden blood loss is hyperventilation, leading to an acute uncompensated respiratory alkalosis; this is probably mediated via pulmonary J receptors in response to vasoactive agents. 29 If the hypovolaemia is treated promptly, there may be no further changes in respiratory function. However, acute respiratory failure due to adult respiratory distress syndrome (ARDS) is being recognised increasingly as a common sequel to severe shock, trauma and sepsis.
This syndrome is initially characterised by tachypnoea, dyspnoea, decreased compliance, a reduced functional residual capacity, and a progressive intrapulmonary shunt, with clinical and radiological evidence of interstitial and alveolar pulmonary oedema. Pulmonary hypertension is an almost universal finding in shock states, but the mechanism by which it occurs is the subject of much debate. 14 Circulating catecholamines, histamine, 5-hydroxytryptamine and the prostaglandin PGF2-alpha have all been implicated; the picture is further complicated by the fact that the lung is normally involved in the metabolism of all these substances. 13 When ARDS was first described, similarities to the neonatal respiratory distress syndrome and cardiogenic pulmonary oedema were emphasised. However, surfactant was subsequently shown to be present in bronchoalveolar lavage fluid from patients with ARDS,30 and the use of pulmonary artery catheters allowed cardiogenic pulmonary oedema to be excluded with confidence. 31 ARDS was then considered a "capillary leak" syndrome of non-cardiogenic pulmonary oedema explicable entirely on the basis of altered Starling forces. Hypoxaemia, acidosis, pulmonary micro-emboli with fat, cellular AllaeSfhesiu (1l1d /lIfensiw> Care, Vol. 12, Nu. 3, August. lY84 debris and infused particulate matter from stored blood, DIC, and a wide variety of vasoactive substances were all implicated in playing a role in causing disruption of the alveloar-capillary membrane. 14 Although considerable experimental evidence supports this concept in the early stages of ARDS, it is now known that the disorder often progresses to involve all structures in the lung. 32 Type 1 alveolar cells are lost and are replaced with proliferating Type II cells, resulting in thickened alveolar septa. The pulmonary interstitium becomes infiltrated with mesenchymal, inflammatory and other cells and pulmonary fibrosis quickly appears and obliterates alveoli, alveolar ducts, and the pulmonary interstitium itself. Capillary obliteration also occurs, and contributes to the pulmonary hypertension. 32 One current hypothesis regarding the pathogenesis of ARDS suggests that complement activation may play a primary role. Complement activation is a common consequence of haemorrhage, trauma and sepsis, and a by-product of complement activation, activated complement fraction 5 (C5a), has been shown to cause leucocyte aggregation in the lung. 33 These neutrophil aggregates injure pulmonary endothelial cells by releasing toxic oxygen radicals 17 and proteases,18 which destroy structural proteins such as collagen, elastin and the adhesive glycoprotein fibronectin ( Table 2 ). These proteases also cleave fibrinogen, Hageman factor and further complement. In this way the interstitial architecture is destroyed, and the stage is set for further leucocyte aggregation and for DIe.
There are many other points at which the coagulation, complement activation, and neutrophil aggregation pathways can potentially interact in the production of ARDS. For example, intra-alveolar complement fragments and leucocytes themselves can initiate clotting, and the products of clots, such as FDPs and platelet factor 4 ( Table 2) , can in turn have chemotactic and stimulatory effects on leucocytes. 14 One product of blood clots, D antigen, has been shown to cause tachypnoea, hypoxaemia and increased aveolar-capillary membrane permeability itself. 14 There is also clinical evidence of these interactions, as about 35 Although the precise role of these and many other interactions in ARDS remains the subject of speculation, there is a statistically highly significant correlation between neutrophil aggregating activity in plasma and the subsequent development of ARDS,36 and the "D antigen" product of fibrin and fibrinogen degradation also appears to be either a marker or a mediator of ARDS. 37 Very little is currently known about the factors which mediate the fibrotic response in ARDS, which in many respects mimics idiopathic pulmonary fibrosis. Alveolar macrophages, activated lymphocytes, prostaglandins, and several other agents have all been implicated. 38 However, most of the other non-fibrotic histological changes appear to be reversible, and, although virtually all survivors have persisting subtle abnormalities of pulmonary function, only one-third have permanent reduction in vital capacity or have significant airway obstruction. 39 Both a hyperoxic environment and the state of alveolar inflation provided by mechanical ventilation with positive end expiratory pressure (PEEP) can probably also affect both the lung injury and lung repair processes associated with ARDS. In lungs already affected by an alveolitis, any oxygen concentration greater than that in air may be harmful. 40 On the other hand, PEEP may have the capacity to limit lung damage, or even prevent the onset of ARDS in predisposed patients by preventing early airway closure. 41 Thus, it now appears that ARDS is a complex disorder which cannot be explained simply on the basis of abnormal Starling forces. Further improvements in patient outcome are unlikely to be derived from improvements in cardiorespiratory support technology, but may follow from a better understanding of the complex pathological processes involved.
THE KIDNEY
After sudden moderate blood loss, kidney blood flow is reduced, but glomerular filtration rate (GFR) is maintained by increased efferent relative to afferent arteriolar tone;9 urine production is markedly reduced due to the release of aldosterone and anti-diuretic hormone (Table 1) and a redistribution of blood flow in the kidney to deep cortical nephrons. 13 In this phase flow in deep cortical nephrons (which have predominantly long loops of Henle) is selectively maintained by a complex mechanism involving prostaglandins, renin, and the sympathetic nerves. 42 However, if the blood loss remains uncorrected or is severe, acute renal failure (ARF) ensues. This is characterised by reduced GFR and the production of small volumes (less than 20 mllhour) of isosthenuric urine. 8 This is another area plagued by experimental difficulties. Despite the existence of numerous experimental models, no single theory has gained widespread acceptance, probably because multiple factors are involved in the initiation, maintenance and recovery phases of ARF.
A variety of mechanisms have been proposed to explain the reduction in GFR seen in ARF.8 There may be diminished glomerular capillary hydrostatic pressure due to systemic arterial hypotension, to afferent arteriolar constriction, to efferent arteriolar dilatation, or to capillary endothelial and/or epithelial cell swelling. There may also be altered glomerular permeability due to toxic or ischaemic events. Finally, there may be increased tubular hydrostatic pressure caused by tubular obstruction or compression. It is also possible that in some circumstances glomerular filtration may not be reduced, but that tubular back-leak of a normally formed filtrate occurs.
The possibility that alterations in renal haemodynamics play an important role in ARF has long been recognised. 43 Significant changes in total renal blood flow (RBF) occur during the initiation and maintenance phases of ARF, with a return to normal in the recovery phase. These changes are not, however, sufficient to explain the dramatic decreases in GFR which occur. Hollenberg suggested that this discrepancy might result from a change in RBF distribution within the kidney;44 cortical ischaemia in ARF has been demonstrated in some experimental models,45 as well as in human ARF cases. 46 The most likely mechanism involves afferent arteriolar vasoconstriction, perhaps mediated by renin, catecholamines, or prostaglandins. 46
Renin release under these circumstances may be an augmentation of the "tubuloglomerular feedback" mechanism in which an increase in intratubular sodium due to proximal tubular ischaemic injury is sensed at the level of the macula densa, which results in the release of renin from juxtaglomerular cells located within the media of the afferent arteriole, leading to the production of angiotensin 11, which mediates afferent arteriolar constriction, leading to a reduction in GFR. There is considerable evidence from both human and experimental studies favouring this general m.echanism. 43 Thus, it appears likely that following ischaemia, tubular dysfunction, not usually accompanied by tubular necrosis, is the major initiating event in the production of ARF due to haemorrhagic shock. This may induce other mechanisms such as tubuloglomerular feedback, tubular obstruction, and back-leak.
THE GASTROINTESTINAL TRACT
Haemorrhagic shock produces profound alpha-receptor mediated vasoconstriction throughout the gastrointestinal tract. 47 The resultant ischaemia is most marked in the mucosal layer , while the submucosa and lamina propria appear to be relatively spared. This mucosal ischaemia may lead to invasion of the circulation by intestinal bacteria or their toxic constituents, with activation of coagulation and complement pathways and release of numerous endogenous mediators including serotonin, prostaglandins, kinins and others 48 ( Tables 1  and 2 ).
Shock-induced mucosal damage is most likely in the stomach, and the incidence of lesions appears to fall progressively further along the gastrointestinal tract, so that shockinduced pathology in the colon is very rare, unless obstruction to major mesenteric vessels has occurred. Changes in the stomach following ischaemia or severe shock have been well described. The earliest of these is apical oedema in the gastric mucosal cells. After 30 minutes, parts of the mucosal cells are extruded, mitochondria begin to swell and platelet aggregation is seen in capillaries. Two hours after the onset of shock, superficial necrosis of the epithelium is seen. There is interstitial oedema of the lamina propria and diffuse microthrombosis of small mucosal vessels. Extensive superficial erosions of mucosa appear after six hours. By the second day, progressive shallow ulcers can be seen. In addition to bleeding from these ulcers, which probably occurs far more commonly than is detected clinically, diffuse petechial bleeding from the stomach may also be seen in shock, and in rare cases, even Mallory-Weiss tears at the gastro-oesophageal junction may follow mucosal microthrombosis due to shock. 49 Lesions of the lower gastrointestinal tract associated with shock also appear to be mediated by microvascular changes associated with ischaemia. 48 These changes include partial or complete obstruction of small vessels by thrombi, excessive local fibrinolysis and spontaneous rupture of small blood vessels, with consequent local bleeding.
THE LIVER
Haemorrhagic shock produces a sympathetic nervous system-mediated vasoconstriction within the liver, which leads to a reduction in both hepatic arterial and portal venous blood flow, and produces the high portal venous pressure relative to central venous pressure which is characteristic of early shock states. 50 The reduced blood flow through the portal system is associated with hypoxia, hypercarbia, lactic acidosis, and raised blood ammonia in portal vein blood, and probably contributes to the ischaemic hepatic cellular changes which are observed, as the liver normally obtains 60070 of its oxygen supply from the portal vein. 51 As the liver serves as a reservoir for venous blood, up to 400 ml of blood may be released from the liver into the systemic circulation within a few minutes of sudden blood loss.
The sinusoidal reticulo-endothelial system is important in removing bacteria and particulate matter from the hepatic circulation, and it is estimated that, under normal circumstances, no more than one bacterium per lOO ml of blood leaves the liver via the hepatic veinsY However, under conditions of low flow and impaired hepatic oxygen delivery, phagocytosis by hepatic reticulo-endothelial cells is markedly depressed, allowing bacteria from the gut to gain access to the systemic circulation. 50 Following shock the hepatic sinusoids are congested and contain red cell aggregates and the central veins, portal tracts and lymphatics Anaesthesia and In/ens/ve Care, Vo/. 12. No. 3, August, 1984 are dilated. There is generalised intracellular oedema, including swelling of mitochondrial matrices, and release of lysozomal and cytoplasmic enzymes. This is reflected by rising concentrations of aspartate aminotransferase (AST), alanine aminotransferase (AL T), lactate dehydrogenase (LDH), and malate dehydrogenase (MOH) in peripheral blood. The magnitude of these rising concentrations is a significant predictor of mortalityY Most of these changes have a centrilobular distribution, supporting the hypothesis that liver cell hypoxia is a major causative factor in their production. However, up to 50% of patients who have suffered trauma also have raised blood alcohol levels, and this may be a significant factor in the production of these changes in some patients. 50 
THE PANCREAS
The pancreas is a metabolically active organ, the normal functions of which include the synthesis of potent proteolytic enzymes as well as hormones known to be of importance in metabolic aspects of shock (see Metabolic and Cellular Changes). The pancreas is known to suffer intense ischaemia during haemorrhagic shock, with up to 85% reduction of blood flow; this ischaemia has been shown to persist after blood volume replacement. 54 In addition, pancreatic lysozomes are especially sensitive to hypoxia and readily release proteolytic enzymes into the cell. 55 As a result, several of the most vasoactive and cardio-depressant polypeptides released into the systemic circulation during shock are derived from the pancreas ( Table 2 ). These peptides represent cellular proteins fragmented by lysozomal and zymogen enzymes. 13 At least nine have been isolated, all of which are potent negative inotropes. The archetype of this group is myocardial depressant factor (MDF), which probably interferes with calcium-mediated excitation-contraction coupling. MDF is also a splanchnic vasoconstrictor and impairs reticuloendothelial function. A lung permeability factor (LPF) is also derived from the pancreas, and may have a role in the production of ARDS.
METABOLIC AND CELLULAR CHANGES
Haemorrhagic shock is associated with hyperglycaemia and an abnormality of glucose tolerance that persists into the recovery phase. 12 ,13 Noradrenaline release from sympathetic nerve endings inhibits insulin secretion causing hyperglycaemia, and also increases amino acid release from skeletal muscle. Glucagon secretion is increased by catecholamine release, stimulating gluconeogenesis in the liver, and, to some extent, the kidney, as well as producing free fatty acid and glycerol release from adipose tissue. Glycogenolysis occurs in both skeletal muscle and the liver, and further contributes to the hyperglycaemia. In addition to low circulating insulin levels, insulin resistance is present in shock, and was formerly ascribed to adrenal catecholamine and glucocorticoid release. More recent work suggests that this insulin resistance is independent of catecholamine and glucocorticoid levels, and cyclic AMP depletion has been suggested as the mechanism, but this remains unresolved. 56 The combination of high glucagon and low insulin levels thus results in net production of glucose, free fatty acids and ketones during haemorrhage at the expense of protein, which is converted to amino acids and thence to glucose and urea, resulting in a negative nitrogen balance. 12 However, the response of protein metabolism to haemorrhagic shock is complex, with both anabolic and catabolic rates of different proteins changing in different ways. There is general agreement, however, that early after injury protein synthesis in the liver increases, while as shock advances this is replaced by a generalised increase in protein catabolism.
As cells become hypoxic and shift to anaerobic metabolism there is an increase in lactic acid synthesis which results in a metabolic acidosis with an associated hyperkalaemia ( Table 2 ). There is a significant fall in serum calcium levels with a corresponding increase in intracellular calcium levels, possibly due to failure of cell membrane calcium ATPase. 57 The vast amount of available data concerning intracellular changes during shock have been combined to produce a hypothetical sequence of events which might occur as shock progresses. 12 The initial change seems to occur at the cell membrane. The membrane potential decreases, possibly under the influence of catecholamines or other factors, while sodium enters and potassium leaves the cell. The sodium-potassium ATPase pump is activated, ATP is consumed, the mitochondria are stimulated, and cyclic AMP decreases. As the A TP level falls, more sodium enters the cell, and the cell swells, as do the mitochondria and the endoplasmic reticulum. The above alterations lead to decreased metabolic capability, and eventually Iysozomes leak and there is cell destruction. Further leakage of toxic products may promote damage to adj oining cells, and Iysozomes, peptide fragments and cellular debris may circulate producing deleterious effects throughout the body ( Table 2) .58
PRACTICAL IMPLICATIONS
A practical clinical approach to the management of shock is to recognise and treat the cause, to provide symptomatic and supportive treatment, and then to ensure that each link in the oxygen delivery cascade is functioning adequately.
Recognition
Haemorrhagic shock may follow the sudden loss of as little as 15070 of blood volume. Although the cardinal signs of shock (a rapid, thready pulse, cold grey clammy skin, and a confused and restless patient) are widely known, haemorrhagic shock frequently remains unrecognised and untreated for far too long. There are several reasons for this. First, normal healthy individuals may suffer no fall in blood pressure with the sudden loss of up to 25 % of the blood volume, although the loss of this amount may lead to death if unrecognised and untreated. 22 Second, it is not generally recognised that almost complete exsanguination may occur into soft tissues, particularly in areas such as the pelvis and retroperitoneal space, without any obvious swelling, and with a normal haemoglobin concentration in the remaining blood. Third, as the early signs of haemorrhagic shock are the signs of massive sympathetic discharge, they also occur as a result of causes as diverse as acute gastric dilatation, an overdistended bladder, intense pain, and hypoglycaemia. Thus blood loss may not immediately be considered as the cause.
A high index of suspicion, and the early recognition of the combination of postural Anaesthesia alld lnlensive Care. Vol. 12, No. 3, AlIgusf, 1984 hypotension, pale mucous membranes (particularly the gums), and the signs listed above, will often lead to an early diagnosis, allowing early treatment.
Treatment
Aggressive measures must be taken to ensure that normal arterial tensions of oxygen and carbon dioxide are maintained, and that blood volume and cardiac filling pressures are adequate. These measures must be taken whilst the sites of bleeding are identified and bleeding is stopped. Thus both systemic and, if necessary, pulmonary arterial pressures and blood gases should be measured, and sufficient crystalloid, colloid or stored blood infused until repeated measurements of left and right ventricular stroke work and filling pressure demonstrate normovolaemia and normal oxygen availability and consumption. Early recognition of the problem followed by aggressive measures to stop the bleeding and restore blood volume are the cornerstones of management.
The vast amount of research that has been carried out to date has allowed a better appreciation of the pathophysiology of haemorrhagic shock. If diagnosis is delayed or initial treatment is inadequate, prolonged patient support for multi-system failure will be necessary in survivors. A variety of therapeutic measures have been suggested as a result of research into haemorrhagic shock. These include the use of glucocorticoids in both physiological and pharmacological doses, II the use of adrenergic agonists and antagonists, 58 the use of vasoconstrictors and vasodilators,58,59 the use of clotting factors and anticoagulants, 19 the infusion of prostaglandins and prostaglandin inhibitors,l2,13 the use of opiates and opiate antagonists,IO·58 the use of isotonic and hypertonic intravenous fluids,60 and the infusion of cocktails of glucose, insulin and potassium,12.58 of cyclic AMP and nicotinamide, of adenosine and creatinine phosphate, and of A TP and magnesium chloride. 12 However, there have been no controlled trials which suggest that any of these measures will favourably influence the outcome of haemorrhagic shock in man. Thus, so far, in spite of the enormous research time and effort that has been expended, management should be restricted to the diagnosis and treatment of the AnueSlhe.\1lI UI/d illlellsive Care, Vu/. 12, IVO. 3, AUguSf. 1984 cause, to the general support of the patient, and to ensuring that each link in the tissue oxygen delivery chain is functioning adequately.
